Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACK GROUND: Diabetes is increasing at an alarming rate throughout the world and about 80% of diabetic cases live in low and middle income countries. Glycemic control is the most important predictor for diabetic related complications and deaths. Identifying factors associated with glycemic control help health care providers and patients to work in the areas that reduce risks of diabetic related complications and deaths. OBJECTIVES: The aim of this study is to assess the magnitude and factors associated with glycemic control among type 2 diabetic patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. METHODS: Hospital-based cross sectional study was conducted on 412 type 2 diabetic patients who were attending in diabetic clinics at Tikur Anbessa Specialized Hospital. Data were collected through structured interview questionnaire, and data abstraction format to collect information from each patient's medical records from March to April, 2015. Data were entered and analyzed using SPSS version 20 statistical software. Both descriptive and inferential statistics were used to determine magnitude of glycemic control and factors associated with poor glycemic control. RESULT: Median age of participants was 52 years old (IQR = 40-60 years old). From the study participants,51.7% were females. Median duration of living with diabetes since diagnosis was 10 years (IQR: 5-16 years). About 80% of the respondents had uncontrolled fasting blood glucose level. The factors which are significantly associated with poor glycemic control were longer duration of diabetes (AOR = 2.72 95%CI:1.16-6.32), and being on insulin therapy (AOR = 3.01 95% CI: 1.5-5.9). CONCLUSION: A high proportion of patients had poor glycemic control. Longer duration of the disease, and being on drug regimen of insulin were associated with poor glycemic control. Appropriate attention should be given to patients with longer duration of disease and those who are on insulin therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Of these articles, 9 articles were excluded from meta-analyses of different factors due to the fact that some articles did not report factors or did not properly report the factors.25,47-54”
From Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis (2023) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Research works printed but not linked: 1
- Feleke Y, Enquselassie F. An assessment of the health care system for diabetes in Addis Ababa, Ethiopia. Ethiopian journal of health development, 2005; 19(3): 204– 8.
Cited by
Fekadu, G., Bula, K., Bayisa, G., Turi, E., Tolossa, T., & Kebebe, H. (2019) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s232691 · Cited by 111
“Only fasting blood sugar was used to monitor glycemic control in this hospital similar to a previous study done in Addis Ababa, Ethiopia.38 This was due to the unavailability of the service and high cost of the glycated hemoglobin (HbA1c) determination in the governmental hospitals of Ethiopia.”
Abera, R. G., Demesse, E. S., & Boko, W. D. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00974-z · Cited by 116
Glycemic control among diabetic patients in Ethiopia: A systematic review and meta-analysis
Gebreyohannes, E. A., Netere, A. K., & Belachew, S. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0221790 · Cited by 84
Lubaki, J.-P. F., Omole, O. B., & Francis, J. M. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00902-0 · Cited by 87
Yosef, T., Nureye, D., & Tekalign, E. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s321756 · Cited by 77
Bitew, Z. W., Alemu, A., Jember, D. A., Tadesse, E., Getaneh, F. B., Seid, A., & Weldeyonnes, M. (2023) · INQUIRY: The Journal of Health Care Organization, Provision, and Financing · doi:10.1177/00469580231155716 · Cited by 58
Azharuddin, M., Adil, M., Sharma, M., & Gyawali, B. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14717 · Cited by 76
Ketema, D. B., Leshargie, C. T., Kibret, G. D., Assemie, M. A., Alamneh, A. A., Kassa, G. M., & Alebel, A. (2020) · BMC Public Health · doi:10.1186/s12889-020-8425-2 · Cited by 72
Oluma, A., Abadiga, M., Mosisa, G., & Etafa, W. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247634 · Cited by 62
Sheleme, T., Mamo, G., Melaku, T., & Sahilu, T. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00861-7 · Cited by 49
Krzemińska, S. A., Lomper, K., Chudiak, A., Ausili, D., & Uchmanowicz, I. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01628-z · Cited by 64
Abdissa, D., & Hirpa, D. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100154 · Cited by 47
“However, the current study was lower than other studies conducted in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia 80% [10], Mettu, Ethiopia 72.”
ResultGebremariam, A. D., Tiruneh, S. A., Ayele, A. A., Tegegn, H. G., Ayele, B. A., & Engidaw, M. T. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100056 · Cited by 50
Achila, O. O., Ghebretinsae, M., Kidane, A., Simon, M., Makonen, S., & Rezene, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5901569 · Cited by 34
Dedefo, M. G., Abate, S. K., Ejeta, B. M., & Korsa, A. T. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.04.034 · Cited by 44
Tegegne, K. D., Gebeyehu, N. A., Tilahun, L., Yitayew, Y. A., & Kassaw, M. W. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1256024 · Cited by 40
Dimore, A. L., Edosa, Z. K., & Mitiku, A. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282962 · Cited by 40
“This finding was lower than a study done in Tikur Anbesa specialized Hospital (TASH), Ethiopia, which reported 80% [17] of the study participants had poor glycemic control.”
BackgroundResultAzagew, A. W., Mekonnen, C. K., Lambie, M., Shepherd, T. A., & Babatunde, O. O. (2025) · BMC Public Health · doi:10.1186/s12889-025-21828-y · Cited by 41
Gebrie, A., Tesfaye, B., & Sisay, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05655 · Cited by 35
“In Ethiopia, some studies, including a systematic review and metaanalysis, were conducted evaluating the status of glycemic control and some factors associated with it [10, 11, 12, 13, 14, 15, 16, 17].”
BackgroundYazew, K. G., Walle, T., & Azagew, A. (2019) · International Journal of Africa Nursing Sciences · doi:10.1016/j.ijans.2019.100167 · Cited by 31
Ayele, B. H., Roba, H. S., Beyene, A. S., & Mengesha, M. M. (2020) · SAGE Open Medicine · doi:10.1177/2050312120975235 · Cited by 29
Alemu, T., Tadesse, T., & Amogne, G. (2021) · SAGE Open Medicine · doi:10.1177/20503121211023000 · Cited by 32
Legese, G. L., Asres, G., Alemu, S., Yesuf, T., Tesfaye, Y. A., & Amare, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1087437 · Cited by 33
“On the contrary, in a study done at Tikur-Anbessa specialized hospital (61) medication adherence was not associated with glycemic control.”
ResultTegegne, K. D., Gebeyehu, N. A., & Kassaw, M. W. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04655-6 · Cited by 23
Riaz, F., Shaikh, A. A., Anjum, Q., Alqahtani, Y. M., & Shahid, S. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14168 · Cited by 24
Seid, M. A., Ambelu, A., Diress, M., Yeshaw, Y., Akalu, Y., & Dagnew, B. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02292-3 · Cited by 22
“The reason is probably linked to the use of insulin alone that re ects less adherence (42) resulting in deterioration in kidney function, decline β-cell function or increase insulin resistance over time (45) which is associated with poor plasma glucose control and higher risk of severe diabetes.”
BackgroundSahiledengle, B., Assefa, T., Negash, W., Tahir, A., Regasa, T., Tekalegn, Y., Mamo, A., Teferu, Z., Solomon, D., Gezahegn, H., et al. (2022) · Clinical ophthalmology · doi:10.2147/opth.s385806 · Cited by 24
Self-citationDawite, F., Girma, M., Shibiru, T., Kefelew, E., Hailu, T., Temesgen, R., & Abebe, G. (2023) · PLoS ONE · doi:10.1371/journal.pone.0276678 · Cited by 23
Mengistu, M., & Benti, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267527 · Cited by 21
Desse, T. A., Namara, K. M., & Manias, E. (2024) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106241279809 · Cited by 29
“9,10,27 30-32 Although diabetes self-management is an essential element of care, in Ethiopia, experiences of patients in relation to type 2 diabetes self-management has not been comprehensively investigated.”
Bereda, G., & Bereda, G. (2021) · International Archives of Endocrinology Clinical Research · doi:10.23937/2572-407x.1510024 · Cited by 31
Tarekegn, E. T., Gobezie, M. Y., Haile, M. B., & Zerga, A. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-93739-2 · Cited by 24
Adu, F., Poku, C. A., Adu, A., & Owusu, L. B. (2024) · Health Science Reports · doi:10.1002/hsr2.2054 · Cited by 25
“50,62 The explanation for this could be adherence to medication, diet and the fact that after years of living with the disease, there is a high chance of mastering all the recommendations required to maintain good glycemic control.”
BackgroundResultAlor, S. K., Kretchy, I. A., Glozah, F. N., & Adongo, P. B. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100265 · Cited by 16
“Earlier researches revealed that poor glycaemic control increase the risk of diabetes complication in patients requiring more care with related healthcare expenditure and increasing complications and premature deaths [8 – 10].”
BackgroundYimam, M. A., Desse, T. A., & Jarso, H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05671 · Cited by 19
Espinosa, M. M., Almeida, V. R. D. S., & Do Nascimento, V. F. (2021) · Investigación y Educación en Enfermería · doi:10.17533/udea.iee.v39n3e10 · Cited by 12
“The association between elevated HbA1c and the use of insulin was similar to that observed in other national(6-11) and international studies.(13-16) The use of insulin in this population is not effective in maintaining adequate glycemic levels, as DM2 management goes beyond drug therapy.”
BackgroundResultDubale, M., Gizaw, K., & Bosho, D. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-42774-y · Cited by 17
“This finding is lower than the finding from the study conducted in Addis Ababa where 80.3% of the patients had inadequate knowledge about diabetes 28 .”
ResultInfluentialDiabetes mellitus, metabolic syndrome, and physical activity among Ethiopians: A systematic review
Bekele, B. B., Manzar, M. D., Alqahtani, M. M., & Pandi-Perumal, S. R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.031 · Cited by 15
Kidie, A. A., Ayal, B. G., Ayele, T., Fentie, E. A., & Lakew, A. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-19909-8 · Cited by 14
ALTUN, H. K., Özyıldırım, C., Koç, Ş., Aksoy, H. N., Sağir, B., BOZKURT, M. S., & KARASU, H. (2023) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-023-01552-5 · Cited by 10
“It has been shown that besides education level, duration of diabetes, type of treatment [47] and comorbidities negatively affect glycemic control [48, 49].”
BackgroundMengistu, Y., Dedefo, G., Arkew, M., Assefa, G., Jebessa, G., Atnafu, A., Ataro, Z., & Kinde, S. (2021) · Nutrition and Metabolic Insights · doi:10.1177/11786388211035220 · Cited by 11
Traoré, S., Guira, O., Zoungrana, L., Sagna, Y., Bognounou, R., B. Paré, C., Dabourou, D. L., Séré, L., Zemba, D., Dembélé, L. S., et al. (2021) · Open Journal of Internal Medicine · doi:10.4236/ojim.2021.111001 · Cited by 8
Yan, D., Li, X., Wang, Y., & Cai, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1593068 · Cited by 12
Bereda, G., & Bereda, G. (2021) · Diabetes Updates · doi:10.15761/du.1000155 · Cited by 9
“In our study uneducated type 2 diabetic patients had more poor glycemic control than primary, secondary, higher educational level were consistent with the study employed in Ethiopia [31] which displayed the significant difference of poor glycemic control was observed among illiterates than college/university graduates.”
Shimels, T., Kassu, R. A., Bogale, G., Bekele, M., Getnet, M., Getachew, A., Shewamene, Z., & Abraha, M. (2020) · Research Square · doi:10.21203/rs.3.rs-108488/v1 · Cited by 10
“In the same vein, allocation per T2DM and hypertension cases in each facility was determined based on follow up outpatient loads reported in similar settings [17-20].”
BackgroundDessie, G., Wagnew, F., Mulugeta, H., Belachew, A., Negesse, A., Kassa, G. M., Habtewold, T. D., & Parchinski, K. (2020) · Current Therapeutic Research · doi:10.1016/j.curtheres.2020.100585 · Cited by 7
Desse, T. A., Namara, K. M., Yifter, H., & Manias, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051149 · Cited by 11
Parsa, N., Moheb, M., Zibaeenezhad, M. J., Akhormeh, A. K., Trevisan, M., Wallin, L., Zaheri, P. M., Sayadi, M., Razeghian‐Jahromi, I., & Moaref, A. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03083-4 · Cited by 7
“The FBS assessment related to LVH was < 130 mg/dl as controlled and ≥ 130 mg/dl as uncontrolled in diabetic study subjects [12, 26].”
MethodPaing, A. C., Kirk, A. F., Collier, A., Kubiak, T., & CHASTIN, S. F. M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.010 · Cited by 8
Beakal, Z., & Debalke, R. (2019) · International Journal of Nutrition and Metabolism · doi:10.5897/ijnam2018.0245 · Cited by 7
Bayih, A., Dedefo, G., Kinde, S., Alem, M., Negesso, A. E., Baye, A., Abreham, A., Getaneh, A., Akalu, G. T., Bayable, A., et al. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01665-7 · Cited by 12
“Various studies in Ethiopia have revealed a high proportion of uncontrolled T2DM patients and comorbidities related to the condition [19, 20].”
BackgroundBriones, A., Wong, L. I., Flores, D., Guzmán, M., Castellanos-Pérez, M., & Albavera-Hernández, C. (2022) · Revista médica de Chile · doi:10.4067/s0034-98872022000800985 · Cited by 6
Abose, A., Getachew, A., Obsa, F., Bekele, S., Haile, K., & Abose, S. (2024) · African Health Sciences · doi:10.4314/ahs.v24i1.23 · Cited by 9
Kahssay, S. W., & Fisseha, N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288093 · Cited by 5
Abate, S. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.49.007777 · Cited by 3
Seid, M. A., & Dagnew, B. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291674 · Cited by 4
Taye, M., Kotiso, K. S., Efrem, P., & Tarekegn, G. (2022) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v32i3.15 · Cited by 2
“glycemia targets was better than in a previous study in TASH (15).”
ResultInfluentialKassahun, H., Genetu, A., Abuhay, T., & Tesfa, H. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000828 · Cited by 2
Reza, H. M., Hasan, T., Sultana, M., & Faruque, M. O. (2020) · Nutrition & Food Science · doi:10.1108/nfs-09-2020-0343 · Cited by 5
Roy, P. K., & Jha, S. K. (2022) · Journal of Diabetes and Endocrine Association of Nepal · doi:10.3126/jdean.v6i1.50352 · Cited by 3
“There are studies which shows much higher prevalence of poor glycemic control as compared to ours studies done by Tekalegn in Ethiopia (80%) [22], Hai in Pakistan (81.”
ResultLubaki, J.-P. F., Omole, O. B., & Francis, J. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1788561/v1 · Cited by 2
BÜYÜKBAYRAM, Z., & Aydın, L. Z. (2024) · Artuklu Health · doi:10.58252/artukluhealth.1475124 · Cited by 1
“In similar studies, the results revealed that as the disease duration of the patients increased, treatment compliance decreased (Fadare et al., 2015; Tekalegn et al., 2018).”
ResultWorku, Y. B., Tekle, M. T., Bekalu, A. F., & Simegn, M. B. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1320610 · Cited by 1
Tekalign, A. M., Lambero, H., & Motuma, A. (2025) · International Health · doi:10.1093/inthealth/ihaf024 · Cited by 3
“20 , 44 , 45 However, a study conducted at the Gondar University Hospital revealed a high proportion of poor glycaemic control in patients with diabetes for 7 y. 46 This is possibly due to reduced insulin secretion or excessive insulin resistance in those patients.”
Telayneh, A. T., Hunegnaw, D. Y., Tariku, M. K., Bishaw, K. A., & Assemie, M. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-25058-5 · Cited by 1
“If the patient had fasting blood glucose (FBG) 70–130 mg/dl 25 .”
Wang, S., Hu, P., Shen, Z., & Chen, L. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01848-6 · Cited by 1
Ayalew, T. L., Walle, B. G., & Zewudie, B. T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275786 · Cited by 4
Adal, G. M., Demissie, N. G., & Tafere, T. Z. (2023) · Clinical Diabetology · doi:10.5603/dk.a2023.0020 · Cited by 1
Seid, M. A., Diress, M., Akalu, Y., & Mekonnon, B. D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105793 · Cited by 1
Shita, N. G., & Iyasu, A. S. (2021) · doi:10.21203/rs.3.rs-288389/v2 · Cited by 1
“This is in line with studies done at Tikur Anbessa Hospital, Dessie Referral Hospital, South Africa, Limmu Genet Hospital, Malaysia, Ayider Referral Hospital, Palestine, Jordan, and Saudi Arabia (15, 17, 19, 23, 24, 26, 28-30).”
BackgroundResultInfluentialEl-Eshmawy, M. M., Sabri, G., Gomaa, H. M. M., Nasr, A. A., & Mahsoub, N. (2022) · Research Square · doi:10.21203/rs.3.rs-1317374/v1 · Cited by 2
Shita, N. G., & Iyasu, A. S. (2021) · Research Square · doi:10.21203/rs.3.rs-288389/v1 · Cited by 2
Mariye, T., Tadesse, D. B., Atalay, H. T., Teklay, G., Gebremichael, G. B., Teklu, T., Mebrahtom, G., & Aberhe, W. (2020) · Cited by 4
Sheno, B. W., & Reja, A. (2021) · Research Square · doi:10.21203/rs.3.rs-1064545/v1
Asociación entre el control glucémico y el control inhibitorio en pacientes con diabetes tipo 2
Castro-Argüelles, A. A., Nieto-Caraveo, A., Rivera-López, E., & Valadez-Castillo, F. J. (2022) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.21000049
Tekalign, A. M., Lambero, H., Semahegn, A., Motuma, A., & Roba, K. T. (2023) · Research Square · doi:10.21203/rs.3.rs-2958959/v1
Mohammed, F. A., Ali, A. A., & Taye, T. A. (2024) · Research Square · doi:10.21203/rs.3.rs-3842861/v1
Yabebal, Y., Genetu, A., & Wassie, G. T. (2024) · Research Square · doi:10.21203/rs.3.rs-4714071/v1
Hosseinzadeh, S., & Davar, S. (2024) · Health Science Monitor · doi:10.61186/hsm.3.4.358
Hibstu, D. T., Likka, M. H., Areru, H. A., Birhanu, B. E., & Lindtjørn, B. (2025) · medRxiv · doi:10.1101/2025.08.19.25333977
“Despite the growing recognition of diabetes as a public concern, particularly in rural areas, most studies in Ethiopia have relied primarily on fasting blood sugar for diagnosis [17].”
Abrahim, R. Y., Gudu, A., Abdi, D., Nuredin, K., Alemu, S., Azene, K., Lemma, B., & Getachew, O. (2025) · Science Frontiers · doi:10.11648/j.sf.20250603.12
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175640
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175646
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175643
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175637
Tegegne, K. D., Gebeyehu, N. A., & Kassaw, M. W. (2023) · Figshare · doi:10.6084/m9.figshare.22617805
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175634
Tegegne, K. D., Gebeyehu, N. A., & Kassaw, M. W. (2023) · Figshare · doi:10.6084/m9.figshare.22617811
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175655
Abera, R. G., Demesse, E. S., & Boko, W. D. (2022) · Figshare · doi:10.6084/m9.figshare.19314703
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175649
Abera, R. G., Demesse, E. S., & Boko, W. D. (2022) · Figshare · doi:10.6084/m9.figshare.19314700
Tegegne, K. D., Gebeyehu, N. A., & Kassaw, M. W. (2023) · Figshare · doi:10.6084/m9.figshare.22617817
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175652
Fina Lubaki, J.-P., Omole, O. B., & Francis, J. M. (2022) · Figshare · doi:10.6084/m9.figshare.21175658
Tegegne, K. D., Gebeyehu, N. A., & Kassaw, M. W. (2023) · Figshare · doi:10.6084/m9.figshare.22617808
Sheno, B. W., Goush, A. R., & Meshesha, M. D. (2025) · BMC Family Practice · doi:10.1186/s12875-025-03071-x
Mohammad, A. A., Alshraideh, J. A., Yacoub, M. I., & Sabra, M. A. A. (2026) · Frontiers of Nursing · doi:10.2478/fon-2026-0015
Deheye, A. S., Ali, A. O., ileye, A. M., Alaleh, H. O., & Mahamoud, M. F. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200665 · Cited by 1
“Despite the availability of effective pharmacological agents, a large proportion of patients in LMICs fail to achieve the recommended HbA1c target of ≤ 7.0% 7,8.”
InfluentialPoor glycemic control among type II diabetes adult patients in Ethiopia: A systematic review
Alemayue, E. A., Jirata, D., & Mekonnen, S. A. (2025) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_15_25
Metadata
- Authors
- Tekalegn, Y., Addissie, A., Kebede, T., & Ayele, W.
- Affiliations
- Tikur Anbessa Hospital (ET)
- Addis Ababa University (ET)
- Corresponding author
- Tekalegn, Yohannes
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-03-05
- Volume
- 13
- Issue
- 3
- Pages
- e0193442
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5837131
- OpenAlex
- W2792738609
- Cited by
- 101
- References
- 29
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 17 · 2022: 26 · 2021: 15 · 2020: 14 · 2019: 4 · 2018: 1
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glycemic control, type 2 diabetes, fasting blood glucose, insulin therapy, disease duration, diabetes complications
- MeSH terms
- Adult, Blood Glucose, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Ethiopia, Female, Hospitals, Humans, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
